Evaluation of the drug-drug interactions management system for appropriate use of nirmatrelvir/ritonavir: a retrospective observational study
Most patients received appropriate antivirals according to the classification of DDIs, and most patients with concomitant medications requiring temporary adjustment received the recommended DDI management. Our management system is effective in promoting the use of NMV-r in the appropriate patients and managing problematic DDIs.
Authors
- Takeshi Kimura (ORCID: https://orcid.org/0000-0001-5254-3507)
- Kazuhiro Yamamoto (ORCID: https://orcid.org/0000-0002-7513-6725)
- Atsushi Uda
- Kei Ebisawa (ORCID: https://orcid.org/0000-0001-5654-366X)
- Naoki Tamura (ORCID: https://orcid.org/0000-0002-9040-5612)
- Takeshi Tomida (ORCID: https://orcid.org/0009-0009-4223-9320)
- Tomohiro Omura (ORCID: https://orcid.org/0000-0001-5520-253X)
- Naomi Mizuta
- Ikuko Yano (ORCID: https://orcid.org/0000-0001-9517-5628)
- Akiko Tanifuji
- Goh Ohji (ORCID: https://orcid.org/0000-0002-9947-020X)
- Kumiko Matsumoto
- Yuki Matsumoto (ORCID: https://orcid.org/0000-0002-4938-5728)
- Kentaro Iwata
- Masashi Iida
Institutions
- Okayama University (JP)
- Kobe University Hospital (JP)
Publication Details
- Journal
- Journal of Pharmaceutical Health Care and Sciences
- Published
- 2024-09-03
- DOI
- https://doi.org/10.1186/s40780-024-00376-4
- Citations
- 2
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.78